As of Jun 28
| +0.022 / +4.19%|
The 1 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +357.04% increase from the last price of 0.55.
The current consensus among 3 polled investment analysts is to Hold stock in Sunesis Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.